Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Tuninetti

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Cells|December 24, 2021
Biomarkers of Central Nervous System Involvement from Epithelial Ovarian CancerGiulia Scotto, Fulvio Borella, Margherita Turinetto, et al.
Journal of Clinical Medicine|January 25, 2025
PD-1 and PD-L1 Expression in Endometrial Cancer: A Systematic Review of the LiteratureOrazio De Tommasi, Matteo Marchetti, Marta Tripepi, et al.
International Journal of Molecular Sciences|July 13, 2024
The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the LiteratureGiulia Spagnol, Eleonora Ghisoni, Matteo Morotti, et al.
Drugs in Context|July 3, 2025
Pseudoprogression and improvement of quality of life in a patient with advanced endometrial cancer treated with immunotherapy: a case reportValentina Tuninetti, Roberta Danese, Amedeo Calvo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 14, 2025
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT studyGiuseppa Scandurra, Giuseppe Scibilia, Valentina Lombardo, et al.
Cancer Treatment Reviews|September 5, 2022
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysisLucia Musacchio, Anna Amela Valsecchi, Vanda Salutari, et al.
Cancer Treatment Reviews|August 23, 2020
Immunotherapy in cervix cancerLaura Attademo, Valentina Tuninetti, Carmela Pisano, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2024
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosisFederica Galvagno, Valeria Leuci, Annamaria Massa, et al.
Cancers|August 14, 2020
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective ExperienceValentina Tuninetti, Marilena Di Napoli, Eleonora Ghisoni, et al.
Journal of Ovarian Research|May 6, 2020
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancersGloria Mittica, Margherita Goia, Angela Gambino, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Cells|December 24, 2021
Biomarkers of Central Nervous System Involvement from Epithelial Ovarian CancerGiulia Scotto, Fulvio Borella, Margherita Turinetto, et al.
Journal of Clinical Medicine|January 25, 2025
PD-1 and PD-L1 Expression in Endometrial Cancer: A Systematic Review of the LiteratureOrazio De Tommasi, Matteo Marchetti, Marta Tripepi, et al.
International Journal of Molecular Sciences|July 13, 2024
The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the LiteratureGiulia Spagnol, Eleonora Ghisoni, Matteo Morotti, et al.
Drugs in Context|July 3, 2025
Pseudoprogression and improvement of quality of life in a patient with advanced endometrial cancer treated with immunotherapy: a case reportValentina Tuninetti, Roberta Danese, Amedeo Calvo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 14, 2025
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT studyGiuseppa Scandurra, Giuseppe Scibilia, Valentina Lombardo, et al.
Cancer Treatment Reviews|September 5, 2022
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysisLucia Musacchio, Anna Amela Valsecchi, Vanda Salutari, et al.
Cancer Treatment Reviews|August 23, 2020
Immunotherapy in cervix cancerLaura Attademo, Valentina Tuninetti, Carmela Pisano, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2024
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosisFederica Galvagno, Valeria Leuci, Annamaria Massa, et al.
Cancers|August 14, 2020
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective ExperienceValentina Tuninetti, Marilena Di Napoli, Eleonora Ghisoni, et al.
Journal of Ovarian Research|May 6, 2020
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancersGloria Mittica, Margherita Goia, Angela Gambino, et al.
Pageof 4